Literature DB >> 1317396

Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients.

S Obalek1, M Favre, J Szymanczyk, J Misiewicz, S Jablonska, G Orth.   

Abstract

Epidermodysplasia verruciformis (EV) is characterized by an abnormal genetic predisposition to infection with specific types of human papillomavirus (HPV). Specific defects of the cell-mediated immunity and/or of the control of HPV infection in keratinocytes are assumed to be involved in the development of the disease. As a model to test this hypothesis, we have studied the prevalence of EV-specific HPV in skin warts of 56 immunosuppressed patients. All main types of cutaneous HPV (HPV1, 2, 3, 4, 10, and 28) responsible for skin warts in the general population were detected by blot hybridization. EV-specific HPV (HPV5, 20, and 23) were detected in three patients. Four additional patients were found infected with HPV49, first characterized in the course of this study, and found to be related to EV HPV. A most important finding was that HPV5, 20, 23, and 49 were always codetected with HPV3 or the related types HPV10 and 28. None of the specimens showed the typical clinical morphology of EV lesions. In none of these specimens was the specific cytopathic effect of EV recognized; instead that of HPV3 and related types was seen. No evidence for productive EV HPV DNA replication was obtained for the three specimens that could be further analyzed by in situ hybridization. Our data suggest that HPV3 infection favors infection with EV HPV in immunosuppressed patients but that the full expression of EV HPV is usually restricted as in the general population.

Entities:  

Mesh:

Year:  1992        PMID: 1317396     DOI: 10.1111/1523-1747.ep12460892

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients.

Authors:  R J Berkhout; J N Bouwes Bavinck; J ter Schegget
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Novel genital alphapapillomaviruses in baboons (Papio hamadryas anubis) with cervical dysplasia.

Authors:  I L Bergin; J D Bell; Z Chen; M K Zochowski; D Chai; K Schmidt; D L Culmer; D M Aronoff; D L Patton; J M Mwenda; C E Wood; R D Burk
Journal:  Vet Pathol       Date:  2012-03-23       Impact factor: 2.221

3.  HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.

Authors:  Francesca Paolini; Gianfranca Curzio; Marcelo Nazario Cordeiro; Silvia Massa; Luciano Mariani; Fulvia Pimpinelli; Antonio Carlos de Freitas; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 4.  Roots and perspectives of contemporary papillomavirus research.

Authors:  H zur Hausen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients.

Authors:  R J Berkhout; L M Tieben; H L Smits; J N Bavinck; B J Vermeer; J ter Schegget
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 6.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

7.  Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis.

Authors:  M C Deau; M Favre; S Jablonska; L A Rueda; G Orth
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 8.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

9.  Identification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12.

Authors:  Anja Oštrbenk; Boštjan J Kocjan; Lea Hošnjak; Jingjing Li; Qiuju Deng; Anja Šterbenc; Mario Poljak
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

10.  Characterization of two novel gammapapillomaviruses, HPV179 and HPV184, isolated from common warts of a renal-transplant recipient.

Authors:  Lea Hošnjak; Boštjan J Kocjan; Branko Pirš; Katja Seme; Mario Poljak
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.